![Sven-Erik Svehag](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sven-Erik Svehag
Corporate Officer/Principal bei University of Southern Denmark
Aktive Positionen von Sven-Erik Svehag
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Southern Denmark | Corporate Officer/Principal | - | - |
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
National Bact. Laboratory | Corporate Officer/Principal | 14.08.2009 | - |
Karriereverlauf von Sven-Erik Svehag
Ehemalige bekannte Positionen von Sven-Erik Svehag
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Vorstandsvorsitzender | - | 22.11.2013 |
Scandinavian Society of Immunology | Präsident | - | - |
Statistik
International
Dänemark | 4 |
Schweiz | 2 |
Schweden | 2 |
Operativ
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
President | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Government | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Profylakse ApS
![]() Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
World Health Organization
![]() World Health Organization SupranationalGovernment World Health Organization provides voluntary medical services. It is the United Nations' agency for health. WHO is governed by countries that approve funding, programs and policies related to public health and health related social issues through the world health assembly. Some of the health and social issues which the organization addresses are communicable & non-communicable diseases, community & family health, hunger, health technology, mental health, pharmaceuticals and sustainable development. Founded on April 7, 1948, the organization is headquartered in Geneva, Switzerland. | Government |
Scandinavian Society of Immunology | |
National Bact. Laboratory |
- Börse
- Insiders
- Sven-Erik Svehag
- Erfahrung